|1.||Deng, Xi-Yun: 1 article (08/2008)|
|2.||Cao, Ya: 1 article (08/2008)|
|3.||Tang, Min: 1 article (08/2008)|
|4.||Lin, Xu-Chi: 1 article (08/2008)|
|5.||Liu, Su-Fang: 1 article (08/2008)|
|6.||Wang, Hai: 1 article (08/2008)|
|7.||Xiang, Hui: 1 article (08/2008)|
|8.||Li, Wei: 1 article (08/2008)|
10/01/1998 - "Analysis of tumor specimens revealed increased apoptosis in BL tumors from mice treated with Z-LLF-CHO. "
10/01/1998 - "Single doses of Z-LLF-CHO induced statistically significant (P < 0.0001) early tumor regression and a significant (P < 0.0001) delay in tumor progression. "
10/01/1998 - "To determine whether such preferential apoptosis could impact upon tumor growth in vivo, toxicological studies were performed in mice with severe combined immunodeficiency and showed that mice tolerated single interscapular doses of Z-LLF-CHO without unacceptable toxicity. "
08/01/2008 - "In this study, we tested the effect of inducing EBV lytic replication using two NF-kappaB inhibitors: Bay11-7082 and Z-LLF-CHO, to reveal the possibility of targeting EBV-positive cancer therapy with these two NF-kappaB inhibitors. "
10/01/1998 - "BL tumors in the flank were treated interscapularly with Z-LLF-CHO or a comparable dose of the peptidyl alcohol (Z-LLF-OH), which does not induce proteasome inhibition or apoptosis. "
|2.||Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
|1.||NF-kappa B (NF-kB)
|2.||3- (4- methylphenylsulfonyl)- 2- propenenitrile
|3.||Proteasome Endopeptidase Complex (Proteasome)